secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001213900-24-024156
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics enters $947,000 at-the-market equity offering agreement with Ascendiant Capital
--------------------------------------------------------------------------------

- Company entered ATM sales agreement with Ascendiant Capital for up to $947,000 of common stock.
- Agent commission 3.0% of gross proceeds; expenses reimbursement up to $30,000.
- Sales may be made on Nasdaq at market prices; agreement effective until March 2026 or earlier termination.
- Placement Shares subject to General Instruction I.B.6 limitations until public float exceeds $75M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024024156/0001213900-24-024156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024024156/ea0202127-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-024156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer